Calendar Kyowa Kirin Co. Ltd.

Equities

4151

JP3256000005

Market Closed - Japan Exchange 02:00:00 2024-04-23 am EDT 5-day change 1st Jan Change
2,656 JPY -0.02% Intraday chart for Kyowa Kirin Co. Ltd. -0.52% +12.05%

Chart calendar Kyowa Kirin Co. Ltd.

27d9d9eb94fb8c02ed93c7761b.WUb7KXPSFqFSIilwC-ZVq01nXOXIo4kGl3HpgHTqX0Q.P36yGDS2fZk5aVgoYY02migAHYKj0tFv0SWDtjeSAHI9HKMZGbV37hhHWg~3dd76064c07a45836ecc69a69afc3198

Upcoming events on Kyowa Kirin Co. Ltd.

2024-05-06 Q1 2024 Earnings Release
2024-05-08 05:15 pm Association for Research in Vision and Ophthalmology Meeting - Poster Number A0009
2024-06-26 Ex-dividend day for dividende intermédiaire
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-31 Q3 2024 Earnings Release (Projected)
2025-02-10 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on Kyowa Kirin Co. Ltd.

2024-04-15 07:30 pm American Academy of Neurology Meeting
2024-03-09 02:30 pm American Academy of Dermatology Meeting
2024-03-07 American Academy of Dermatology Meeting - Rocatinlimab Significantly Improves Clinical Responses in
2024-02-06 Q4 2023 Earnings Release
2023-12-27 Final dividend
2023-11-02 10:00 am American Society of Nephrology Kidney Conference - Poster Number: TH-PO145
2023-11-02 10:00 am American Society of Nephrology Kidney Conference - Poster Number: TH-PO144
2023-10-31 Q3 2023 Earnings Call
2023-10-31 Q3 2023 Earnings Release
2023-10-15 04:30 pm American Society for Bone and Mineral Research Meeting - Poster #SUN-496
2023-10-15 04:30 pm American Society for Bone and Mineral Research Meeting - Poster #SUN-500
2023-10-14 04:30 pm American Society for Bone and Mineral Research Meeting - Poster #SAT-519
2023-10-14 04:30 pm American Society for Bone and Mineral Research Meeting - Poster #SAT-496
2023-10-14 04:30 pm American Society for Bone and Mineral Research Meeting - Poster #SAT-493
2023-10-10 European Academy of Dermatology and Venereology Congress - Rocatinlimab improves lichenification com
2023-10-10 European Academy of Dermatology and Venereology Congress - Rocatinlimab improves SCORAD compared wit
2023-10-05 05:30 am Acquisition of Orchard Therapeutics Plc by Kyowa Kirin Co.Ltd. Call
2023-10-02 Analyst Meeting - ESG
2023-08-02 Q2 2023 Earnings Call
2023-08-02 Q2 2023 Earnings Release

Past dividends on Kyowa Kirin Co. Ltd.

2023-12-27 Final Payment 29 JPY
2023-06-28 Interim Payment 27 JPY
2022-12-28 Final Payment 27 JPY
2022-06-28 Interim Payment 24 JPY
2021-12-28 Final Payment 23 JPY
2021-06-28 Interim Payment 23 JPY
2020-12-28 Final Payment 22 JPY
2020-06-28 Interim Payment 22 JPY
2019-12-26 Final Payment 22 JPY
2019-06-25 Interim Payment 20 JPY

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million JPY
Released
Forecast
Spread
305 820
305 436
0.13%
318 352
319 922
-0.49%
352 246
350 570
0.48%
398 371
396 550
0.46%
442 233
429 390
2.99%

470 396

EBITDA
Million JPY
Released
Forecast
Spread
74 170
71 401
3.88%
79 456
78 740
0.91%
80 611
84 158
-4.22%
105 176
94 637
11.14%
117 881
109 998
7.17%

107 260

EBIT
Million JPY
Released
Forecast
Spread
55 373
55 148
0.41%
58 990
63 276
-6.77%
61 111
65 891
-7.25%
82 374
78 312
5.19%
95 842
89 370
7.24%

86 284

Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
44 492
45 206
-1.58%
52 263
57 422
-8.98%
60 050
62 960
-4.62%
67 572
70 333
-3.93%
97 246
91 459
6.33%

87 048

Net income
Million JPY
Released
Forecast
Spread
67 084
65 391
2.59%
47 027
47 510
-1.02%
52 347
49 081
6.65%
53 573
54 481
-1.67%
81 188
73 168
10.96%

66 381

EPS
JPY
Released
Forecast
Spread
125
121
3.08%
87,6
87,5
0.08%
97,4
91,3
6.74%
99,7
101
-1.68%
151
136
10.96%

125

Announcement Date05/02/2004/02/2107/02/2207/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales
Million JPY
Released
Forecast
Spread
154 404
152 541
1.22%
157 819
159 000
-0.74%
165 021
172 267
-4.21%
98 277
98 910
-0.64%
87 751
90 640
-3.19%
97 520
95 150
2.49%
185 271
181 550
2.05%
98 504
102 900
-4.27%
114 596
109 875
4.3%
93 535
100 141
-6.6%
105 674
110 283
-4.18%
199 209
204 234
-2.46%
106 844
111 138
-3.86%
136 180
119 018
14.42%

104 728


113 081


216 813


117 956


134 678

EBITDA
Million JPY
Released
Forecast
Spread







































41 558
30 327
37.03%

23 196


23 873





26 516


33 755

EBIT
Million JPY
Released
Forecast
Spread
22 760
24 595
-7.46%
34 564
32 500
6.35%
30 949
35 800
-13.55%
14 291
18 711
-23.62%
17 340
16 563
4.69%
20 192
17 379
16.19%
37 532
35 100
6.93%
20 683
19 306
7.13%
24 159
19 108
26.43%
16 177
20 188
-19.87%
20 500
26 400
-22.35%
37 500
46 203
-18.84%
23 405
28 757
-18.61%
34 937
24 441
42.94%

18 532


19 205


39 933


23 593


25 603

Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
22 663
23 821
-4.86%
30 872
32 200
-4.12%
31 102
35 600
-12.63%
18 160
18 007
0.85%
18 716
16 617
12.63%
24 763
17 229
43.73%
43 479
34 650
25.48%
16 925
20 106
-15.82%
7 168


15 582
20 159
-22.7%
10 464
27 800
-62.36%
26 046
46 328
-43.78%
38 293
40 677
-5.86%
32 907
18 250
80.31%

18 746


19 445


40 058


23 837


25 843

Net income
Million JPY
Released
Forecast
Spread
19 021
17 755
7.13%
27 798
24 900
11.64%
25 072
27 800
-9.81%
19 439
14 107
37.8%
16 038
13 183
21.65%
18 979
13 579
39.77%
35 017
27 750
26.19%
14 195
15 756
-9.91%
4 361


12 760
16 004
-20.27%
8 886
22 600
-60.68%
21 646
37 353
-42.05%
31 908
36 527
-12.65%
27 634
12 215
126.23%

13 639


14 907


29 946


18 912


18 654

EPS
JPY
Released
Forecast
Spread



51,8
46,4
11.55%
46,7
51,9
-10.08%
36,2
22,1
63.86%
29,9
24,9
20.02%
35,3
24,4
44.97%
65,2
51,5
26.52%
26,4
28,9
-8.58%
8,11
4,25
90.82%
23,7
28,6
-17.07%
16,5
29,8
-44.6%
40,3
73,3
-45.06%
59,4
46,3
28.06%
51,4
41,4
24.33%

28,9


34,4


79,1


34,7


28,4

Announcement Date05/02/2030/07/2003/08/2107/02/2210/05/2204/08/2204/08/2204/11/2207/02/2310/05/2303/08/2303/08/2301/11/2307/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4151 Stock
  4. Calendar Kyowa Kirin Co. Ltd.